Transforming Growth Factor-β (TGF-β ) and its Role in the Pathogenesis of Systemic Sclerosis: A Novel Target for Therapy?
Recent Patents on Inflammation & Allergy Drug Discovery · 2007
DOI: 10.2174/187221307780979883 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Recent Patents on Inflammation & Allergy Drug Discovery, 2007. Verfasst von Chris T Derk. Beteiligte Einrichtung: Division of Rheumatology, Thomas Jefferson University, Philadelphia, PA 19107, USA. Chris.Derk@jefferson.edu. Hauptthemen laut MEDLINE: Drug Delivery Systems. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Thomas Jefferson University, Philadelphia, PA 19107, USA. Chris.Derk@jefferson.edu
Zitieren
APA
Derk, C. T. (2007). Transforming Growth Factor-β (TGF-β ) and its Role in the Pathogenesis of Systemic Sclerosis: A Novel Target for Therapy?. Recent Patents on Inflammation & Allergy Drug Discovery. https://doi.org/10.2174/187221307780979883
Vancouver
Derk CT. Transforming Growth Factor-β (TGF-β ) and its Role in the Pathogenesis of Systemic Sclerosis: A Novel Target for Therapy?. Recent Patents on Inflammation & Allergy Drug Discovery. 2007. doi:10.2174/187221307780979883
BibTeX
@article{Derk2007,
author = {Derk, Chris T},
title = {Transforming Growth Factor-β (TGF-β ) and its Role in the Pathogenesis of Systemic Sclerosis: A Novel Target for Therapy?},
journal = {Recent Patents on Inflammation & Allergy Drug Discovery},
year = {2007},
doi = {10.2174/187221307780979883}
}
EUVIMED